Porth Ymchwil

Oral cancer screening: what have we learnt and what is there still to achieve?

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

StandardStandard

Oral cancer screening: what have we learnt and what is there still to achieve? / Brocklehurst, Paul R; Baker, Sarah R; Speight, Paul M.
Yn: Future Oncology , Cyfrol 6, Rhif 2, 02.2010, t. 299-304.

Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid

HarvardHarvard

Brocklehurst, PR, Baker, SR & Speight, PM 2010, 'Oral cancer screening: what have we learnt and what is there still to achieve?', Future Oncology , cyfrol. 6, rhif 2, tt. 299-304. https://doi.org/10.2217/fon.09.163

APA

Brocklehurst, P. R., Baker, S. R., & Speight, P. M. (2010). Oral cancer screening: what have we learnt and what is there still to achieve? Future Oncology , 6(2), 299-304. https://doi.org/10.2217/fon.09.163

CBE

Brocklehurst PR, Baker SR, Speight PM. 2010. Oral cancer screening: what have we learnt and what is there still to achieve?. Future Oncology . 6(2):299-304. https://doi.org/10.2217/fon.09.163

MLA

Brocklehurst, Paul R, Sarah R Baker a Paul M Speight. "Oral cancer screening: what have we learnt and what is there still to achieve?". Future Oncology . 2010, 6(2). 299-304. https://doi.org/10.2217/fon.09.163

VancouverVancouver

Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening: what have we learnt and what is there still to achieve? Future Oncology . 2010 Chw;6(2):299-304. doi: 10.2217/fon.09.163

Author

Brocklehurst, Paul R ; Baker, Sarah R ; Speight, Paul M. / Oral cancer screening : what have we learnt and what is there still to achieve?. Yn: Future Oncology . 2010 ; Cyfrol 6, Rhif 2. tt. 299-304.

RIS

TY - JOUR

T1 - Oral cancer screening

T2 - what have we learnt and what is there still to achieve?

AU - Brocklehurst, Paul R

AU - Baker, Sarah R

AU - Speight, Paul M

PY - 2010/2

Y1 - 2010/2

N2 - Oral cancer is an important global healthcare problem. In the UK, the incidence is increasing and late-stage presentation is common. Determining the feasibility of a national screening program for oral cancer is therefore an important step in the prevention of the disease. Evidence exists to suggest that an oral examination of high-risk individuals may be a cost-effective screening strategy. However, questions remain over which primary care environment would be the most suitable and the criteria for a positive screen and referral. Further research is needed in the form of clinical trials or demonstration studies in primary care. The impact on secondary care, the role of auxiliaries and training needs also need to be determined. In addition, the assessment of adjunctive aids and evaluation of potential biomarkers are considered important.

AB - Oral cancer is an important global healthcare problem. In the UK, the incidence is increasing and late-stage presentation is common. Determining the feasibility of a national screening program for oral cancer is therefore an important step in the prevention of the disease. Evidence exists to suggest that an oral examination of high-risk individuals may be a cost-effective screening strategy. However, questions remain over which primary care environment would be the most suitable and the criteria for a positive screen and referral. Further research is needed in the form of clinical trials or demonstration studies in primary care. The impact on secondary care, the role of auxiliaries and training needs also need to be determined. In addition, the assessment of adjunctive aids and evaluation of potential biomarkers are considered important.

KW - Early Detection of Cancer

KW - Humans

KW - Mass Screening

KW - Mouth Neoplasms

KW - Journal Article

KW - Review

U2 - 10.2217/fon.09.163

DO - 10.2217/fon.09.163

M3 - Article

C2 - 20146588

VL - 6

SP - 299

EP - 304

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 2

ER -